Biogen (BIIB) PT Raised to $369 at Morgan Stanley
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $222.67 --0%
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 11 | New: 20
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 11 | New: 20
Join SI Premium – FREE
Morgan Stanley raised its price target on Biogen (NASDAQ: BIIB) to $369.00 (from $365.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Snowflake Inc. (SNOW) PT Raised to $470 at Morgan Stanley
- Morgan Stanley Upgrades NIBE Industrier AB (NIBEB:SW) (NDRBF) to Equalweight
- Snowflake Inc. (SNOW) PT Raised to $430 at Cantor Fitzgerald
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
